- Home
- NVNI vs CLSD Comparison
NVNI vs CLSD Comparison
Compare NVNI & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- CLSD
- Stock Information
- Founded
- NVNI 2019
- CLSD 2011
- Country
- NVNI Brazil
- CLSD United States
- Employees
- NVNI N/A
- CLSD N/A
- Industry
- NVNI
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- CLSD Health Care
- Exchange
- NVNI Nasdaq
- CLSD Nasdaq
- Market Cap
- NVNI 57.2M
- CLSD 68.4M
- IPO Year
- NVNI N/A
- CLSD 2016
- Fundamental
- Price
- NVNI $0.61
- CLSD $3.96
- Analyst Decision
- NVNI
- CLSD Hold
- Analyst Count
- NVNI 0
- CLSD 4
- Target Price
- NVNI N/A
- CLSD $4.33
- AVG Volume (30 Days)
- NVNI 2.1M
- CLSD 652.7K
- Earning Date
- NVNI 09-30-2025
- CLSD 11-11-2025
- Dividend Yield
- NVNI N/A
- CLSD N/A
- EPS Growth
- NVNI N/A
- CLSD N/A
- EPS
- NVNI N/A
- CLSD N/A
- Revenue
- NVNI $31,250,627.00
- CLSD $4,166,000.00
- Revenue This Year
- NVNI $12.05
- CLSD $98.20
- Revenue Next Year
- NVNI $15.02
- CLSD $213.77
- P/E Ratio
- NVNI N/A
- CLSD N/A
- Revenue Growth
- NVNI 1491.58
- CLSD N/A
- 52 Week Low
- NVNI $0.14
- CLSD $0.29
- 52 Week High
- NVNI $12.19
- CLSD $4.43
- Technical
- Relative Strength Index (RSI)
- NVNI 54.71
- CLSD 96.21
- Support Level
- NVNI $0.52
- CLSD $0.32
- Resistance Level
- NVNI $0.57
- CLSD $0.36
- Average True Range (ATR)
- NVNI 0.04
- CLSD 0.07
- MACD
- NVNI -0.00
- CLSD 0.24
- Stochastic Oscillator
- NVNI 62.24
- CLSD 88.63
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.